Valuation: Virbac

Capitalization 306.21Cr 362.16Cr 279.64Cr 267.71Cr 494.58Cr 33TCr 512.72Cr 3.26TCr 1.29TCr 16TCr 1.36TCr 1.33TCr 56TCr P/E ratio 2025 *
19.9x
P/E ratio 2026 * 17.5x
Enterprise value 317.46Cr 375.47Cr 289.92Cr 277.55Cr 512.75Cr 34TCr 531.55Cr 3.38TCr 1.34TCr 16TCr 1.41TCr 1.38TCr 58TCr EV / Sales 2025
2.04x
EV / Sales 2026 * 1.99x
Free-Float
47.73%
Yield 2025 *
0.44%
Yield 2026 * 0.49%
1 day-0.41%
1 week+2.25%
Current month+3.56%
1 month+4.15%
3 months+2.97%
6 months+8.33%
Current year+1.82%
1 week 355
Extreme 355
365.5
1 month 342
Extreme 342
371.5
Current year 342
Extreme 342
371.5
1 year 249.7
Extreme 249.7
371.5
3 years 232.5
Extreme 232.5
400
5 years 200.5
Extreme 200.5
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Compliance Officer 65 01/01/2023
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 66 28/07/2010
Director/Board Member 65 05/09/2017
Change 5d. change 1-year change 3-years change Capi.($)
-0.41%+2.25%+17.61%+23.39% 362.16Cr
-0.86%-2.01%-20.29%-27.01% 5.3TCr
-1.07%-2.93%+120.98%+89.34% 1.24TCr
-3.63%+1.00%-10.54%+13.74% 450.34Cr
-1.71%-1.65%+133.58%+34.17% 245.37Cr
+0.06%+1.06%+102.91%+219.43% 211.96Cr
-0.86%+6.05%-43.16%-2.13% 157.47Cr
-0.89%-1.46%+11.41%-5.63% 124.51Cr
+0.45%+1.72%+22.21%+6.49% 123.05Cr
-0.65%-1.79%+17.10%-48.21% 113.39Cr
Average -0.96%-0.02%+35.18%+30.36% 832.37Cr
Weighted average by Cap. -1.00%-1.45%+11.70%+3.73%

Financials

2025 2026 *
Net sales 146.85Cr 173.68Cr 134.11Cr 128.39Cr 237.19Cr 16TCr 245.88Cr 1.56TCr 619.53Cr 7.59TCr 651.4Cr 637.95Cr 27TCr 155.3Cr 183.68Cr 141.83Cr 135.78Cr 250.84Cr 17TCr 260.04Cr 1.65TCr 655.2Cr 8.03TCr 688.9Cr 674.69Cr 28TCr
Net income 16Cr 19Cr 14Cr 14Cr 25Cr 1.68TCr 26Cr 166.82Cr 66Cr 809.75Cr 69Cr 68Cr 2.84TCr 18Cr 21Cr 16Cr 16Cr 29Cr 1.9TCr 30Cr 189.15Cr 75Cr 918.16Cr 79Cr 77Cr 3.23TCr
Net Debt 11Cr 13Cr 10Cr 9.84Cr 18Cr 1.21TCr 19Cr 119.86Cr 47Cr 581.8Cr 50Cr 49Cr 2.04TCr 3.39Cr 4.01Cr 3.1Cr 2.97Cr 5.48Cr 363.87Cr 5.68Cr 36Cr 14Cr 175.51Cr 15Cr 15Cr 616.62Cr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (61.6%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (38.4%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (40.8%), Latin America (15.9%), North America (13%), India/Africa/Middle East (12.5%), East Asia (10.1%) and Pacific (7.7%).
Employees
6,365
Date Price Change Volume
18/26/18 366.50 +0.27% 1,103
17/26/17 365.50 +1.67% 3,651
16/26/16 359.50 0.00% 3,094
13/26/13 359.50 +0.42% 4,256
12/26/12 358.00 +0.56% 3,613
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
365.50EUR
Average target price
412.82EUR
Spread / Average Target
+12.95%

Quarterly revenue - Rate of surprise